PHARMACOGENETIC HLA-B☆58:01 TESTING TO PREVENT ALLOPURINOL-INDUCED SJS']JS/TEN IN VIETNAMESE POPULATION: A COST-EFFECTIVENESS ANALYSIS

被引：0
|
作者：
Duong, K. [1 ]
Nguyen, D., V [2 ]
Chaiyakunapruk, N. [1 ]
Nelson, R. E. [3 ]
Malone, D. C. [1 ]
机构：
[1] Univ Utah, Coll Pharm, Dept Pharmacotherapy, Salt Lake City, UT USA
[2] Vinmec Healthcare Syst, Dept Internal Med, Resp Allergy & Clin Immunol Unit, Hanoi, Vietnam
[3] Univ Utah, Sch Med, Div Epidemiol, Salt Lake City, UT USA
来源：
VALUE IN HEALTH | 2023年 / 26卷 / 06期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
EE94
引用
收藏
页码：S76 / S77
页数：2
相关论文
共 40 条
  • [21] Development of a HLA-B*58:01 Allele Screening System for Allopurinol-Induced Severe Cutaneous Adverse Reactions Detection
    Gan, Kok Beng
    Chong, Kim Soon
    Nawoor, Anusha Devi
    Then, Sue-Mian
    Abdul Murad, Nor Azian
    A. Jamal, A. Rahman
    [J]. IEEE ACCESS, 2020, 8 : 225306 - 225323
  • [22] HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
    Goncalo, M.
    Coutinho, I.
    Teixeira, V.
    Gameiro, A. R.
    Brites, M. M.
    Nunes, R.
    Martinho, A.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2013, 169 (03) : 660 - 665
  • [23] Association between the HLA-B alleles and carbamazepine-induced SJS']JS/TEN: A meta-analysis
    Wang, Qianyu
    Sun, Shusen
    Xie, Meng
    Zhao, Kun
    Li, Xingang
    Zhao, Zhigang
    [J]. EPILEPSY RESEARCH, 2017, 135 : 19 - 28
  • [24] HLA-B*58:01 association in allopurinol-induced severe cutaneous adverse reactions: the implication of ethnicity and clinical phenotypes in multiethnic Malaysia
    Low, Dyoi E.
    Nurul-Aain, Ahmad Fauzi
    Tan, Wooi Chiang
    Tang, Jyh Jong
    Bakhtiar, Mohammed Faizal
    Murad, Shahnaz
    Chang, Choong Chor
    Too, Chun Lai
    Tang, Min Moon
    [J]. PHARMACOGENETICS AND GENOMICS, 2020, 30 (07): : 153 - 160
  • [25] HLA-B*58:01 and allopurinol high dose were associated with allopurinol induced cutaneous adverse drug reactions in Thai population
    Sukasem, C.
    Jantararoungtong, T.
    Kuntawong, P.
    Puangpetch, A.
    Koomdee, N.
    Klaewsongkram, J.
    Rerkpattanapipat, T.
    [J]. ALLERGY, 2016, 71 : 205 - 206
  • [26] Validation of a Rapid, Robust, Inexpensive Screening Method for Detecting the HLA-B*58:01 Allele in the Prevention of Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Nguyen, Dinh Van
    Vidal, Christopher
    Chu, Hieu Chi
    Fulton, Richard
    Li, Jamma
    Fernando, Suran L.
    [J]. ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2017, 9 (01) : 79 - 84
  • [27] Comparison between the HLA-B*58: 01 Allele and Single-Nucleotide Polymorphisms in Chromosome 6 for Prediction of Allopurinol-Induced Severe Cutaneous Adverse Reactions
    Saksit, Niwat
    Nakkam, Nontaya
    Konyoung, Parinya
    Khunarkornsiri, Usanee
    Tassaneeyakul, Wongwiwat
    Chumworathayi, Pansu
    Kanjanawart, Sirimas
    Sukasem, Chonlaphat
    Sangviroon, Alisara
    Pattanacheewapull, Oranuch
    Tassaneeyakul, Wichittra
    [J]. JOURNAL OF IMMUNOLOGY RESEARCH, 2017, 2017
  • [28] Use of HLA-B*58:01 genotyping to prevent allopurinol induced severe cutaneous adverse reactions in Taiwan: national prospective cohort study
    Ko, Tai-Ming
    Tsai, Chang-Youh
    Chen, Shih-Yang
    Chen, Kuo-Shu
    Yu, Kuang-Hui
    Chu, Chih-Sheng
    Huang, Chung-Ming
    Wang, Chrong-Reen
    Weng, Chia-Tse
    Yu, Chia-Li
    Hsieh, Song-Chou
    Tsai, Jer-Chia
    Lai, Wen-Ter
    Tsai, Wen-Chan
    Yin, Guang-Dar
    Ou, Tsan-Teng
    Cheng, Kai-Hung
    Yen, Jeng-Hsien
    Liou, Teh-Ling
    Lin, Tsung-Hsien
    Chen, Der-Yuan
    Hsiao, Pi-Jung
    Weng, Meng-Yu
    Chen, Yi-Ming
    Chen, Chen-Hung
    Liu, Ming-Fei
    Yen, Hsueh-Wei
    Lee, Jia-Jung
    Kuo, Mei-Chuan
    Wu, Chen-Ching
    Hung, Shih-Yuan
    Luo, Shue-Fen
    Yang, Ya-Hui
    Chuang, Hui-Ping
    Chou, Yi-Chun
    Liao, Hung-Ting
    Wang, Chia-Wen
    Huang, Chun-Lin
    Chang, Chia-Shuo
    Lee, Ming-Ta Michael
    Chen, Pei
    Wong, Chih-Shung
    Chen, Chien-Hsiun
    Wu, Jer-Yuarn
    Chen, Yuan-Tsong
    Shen, Chen-Yang
    [J]. BMJ-BRITISH MEDICAL JOURNAL, 2015, 351
  • [29] Role of HLA-B*5801 Genetic Testing and Enhanced Safety Program When Initiating Allopurinol for Chronic Gout Management: A Cost-Effectiveness Analysis
    Dong, D.
    Tan-Koi, W. C.
    Teng, G. G.
    Finkelstein, E.
    Sung, C.
    [J]. PUBLIC HEALTH GENOMICS, 2015, 18 : 10 - 10
  • [30] Role of HLA-B*5801 Genetic Testing and a Safety Programme When Initiating Allopurinol Therapy for Chronic Gout Management: A Cost-Effectiveness Analysis
    Dong, Di
    Tan-Koi, Wei Chuen
    Teng, Gim Gee
    Finkelstein, Eric
    Sung, Cynthia
    [J]. ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S793 - S794
1234